publications 

Fall 2024 Prime Therapeutics Report 

October 21, 2024
Debuting a new name and design, the 41st edition of our managed care report still offers the same in-depth industry articles on trending specialty topics. 

Get the latest updates on CAR T therapy, non-small cell lung cancer, oncology accelerated approval, acute myeloid leukemia, and more!

Explore the report 
Login Portals
Compliance / Legal
Careers
© 2025 Prime Therapeutics LLC